Integrating androgen deprivation therapy with metastasis-directed therapy leads to improved progression-free survival – IOSI Oncology Institute of Southern Switzerland – EOC
IOSI Oncology Institute of Southern Switzerland – EOC made the following post on LinkedIn:
“New publication! A collaborative research effort involving physicians from the IOSI Istituto Oncologico della Svizzera Italiana – EOC has now been published in the international journal European Urology Oncology.
The study presents findings from a multicentric retrospective data analysis examining the efficacy of metastasis-directed radiotherapy with or without androgen deprivation therapy in patients with oligometastatic prostate cancer. Remarkably, the research demonstrates that integrating androgen deprivation therapy with metastasis-directed therapy leads to improved progression-free survival. Congratulations Prof. Silke Gillessen, Dr. Davide Bosetti and all authors!
Link to the article.”
Source: IOSI Oncology Institute of Southern Switzerland – EOC/LinkedIn